SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck. Symptoms include, head ...

Upadacitinib expands treatment options for patients with giant cell arteritis; Tapering steroids without symptoms recurring is one of the bigger challenges when monitoring GCA. Healio spoke with ...

NORTH CHICAGO, Ill., Feb. 28, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive ...

Please provide your email address to receive an email when new articles are posted on . Although it is known that the selective Janus kinase (JAK) inhibitor upadacitinib (Rinvoq, AbbVie) blocks the ...

An observational study was conducted across three Spanish hospitals to compare two glucocorticoid regimens in treating 151 patients newly diagnosed with giant cell arteritis (mean age, 74.6 years; 71% ...

Findings showed 46% of patients who received upadacitinib 15mg achieved sustained remission at week 52 compared with 29% of patients who received placebo. Patients with giant cell arteritis (GCA) who ...

Recent advances in the study of inflammatory vasculitides have underscored the complexity of both giant cell arteritis (GCA) and Takayasu arteritis (TAK). Research has increasingly revealed the ...

AbbVie (NYSE:ABBV) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed Upadacitinib as a treatment for giant cell arteritis, an autoimmune ...

SHREVEPORT, La. -- Patients who have a condition called giant cell arteritis are concerned it could be going undiagnosed. Dr. Robert Goodman of The Arthritis and Rheumatology Clinic in Shreveport ...

Other major complications of GCA include stroke, MI, aortic aneurysm, and visceral organ infarcts due to the occlusion of large arteries. 1,4 While early diagnosis and treatment may decrease the ...

Cosentyx missed primary endpoint in GCA trial but reduced steroid use and toxicity compared to placebo. Cosentyx sales rose 16% year over year to $1.5 billion in Q1 2025, driven by demand across ...

Dear Doctor: I was recently diagnosed with giant cell arteritis, but I don't know what it is or how to treat it. My pain is above my right eye, and it gets worse when I'm eating. Dear Reader: Giant ...